Therapeutic Plasma Exchange in Pediatric Patients: A Multi-Institutional Landscape Analysis.
- 1Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Abstract
Pediatric evidence for therapeutic plasma exchange (TPE) is largely small, single-center cohorts; there is no prior large-scale age-stratified outcomes assessment. Using the TriNetX US Collaborative Network, we identified 3744 patients ≤ 17 years old undergoing an index TPE procedure, stratified into four age groups (≤ 1, 2-5, 6-12, and 13-17 years). ICD-10-CM diagnosis codes recorded 30 days prior to the index procedure were mapped to American Society for Apheresis Categories I-III indications; three high-prevalence nonspecific codes were tracked separately. All-cause mortality at 30 days, 90 days, and 1 year was assessed. All-cause mortality decreased with increasing age at every time window: 30-day mortality ranged from 16.8% (≤ 1 year) to 4.3% (13-17 years, p < 0.0001). Infant mortality risk was concentrated disproportionately in the first 90 days postprocedure. Sex distribution shifted from a slight male predominance in infancy and early childhood (55%-56% male) to a female predominance in adolescence (55% female, p < 0.0001). Leading specific indications were autoimmune encephalitis (10%), sepsis with multiorgan failure (9%), renal transplant rejection (6%), acute disseminated encephalomyelitis (5%), Guillain-Barré syndrome (5%), and myasthenia gravis (4%); nonspecific diagnosis codes were each individually more prevalent than any single ASFA-mapped indication. This is the first large-scale, age-stratified, multi-institutional characterization of pediatric TPE. We identified an inverse relationship between age and all-cause mortality, a sex-distribution shift in adolescence, and an indication landscape dominated by nonspecific diagnosis codes. These findings offer age-stratified benchmarks for clinical counseling and hypothesis generation.
Related
- Clinical characteristics and outcomes of 144 critically ill children receiving therapeutic plasma exchange in a pediatric intensive care unit: a single-center retrospective study
- Integrated multi-omics analysis reveals the molecular landscape and therapeutic strategies in Chinese cervical cancer patients
- Clinical and Therapeutic Profile of Dravet Syndrome in Patients Followed at a Brazilian Pediatric Referral Center: Real-World Data from a Tertiary Service
- Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study
- Lamotrigine-associated SJS/TEN overlap during valproate co-therapy managed with rhTNFR-Fc and therapeutic plasma exchange : A case report
BibTeX
@article{raymond2026therapeutic,
title = {{Therapeutic Plasma Exchange in Pediatric Patients: A Multi-Institutional Landscape Analysis.}},
author = {Caitlin Raymond},
journal = {Journal of clinical apheresis},
year = {2026},
month = oct,
doi = {10.1002/jca.70198},
url = {https://europepmc.org/article/MED/42897738},
note = {CC BY},
}
RIS
TY - JOUR
TI - Therapeutic Plasma Exchange in Pediatric Patients: A Multi-Institutional Landscape Analysis.
AU - Caitlin Raymond
PY - 2026
DA - 2026/10/01
JO - Journal of clinical apheresis
DO - 10.1002/jca.70198
UR - https://europepmc.org/article/MED/42897738
AB - Pediatric evidence for therapeutic plasma exchange (TPE) is largely small, single-center cohorts; there is no prior large-scale age-stratified outcomes assessment. Using the TriNetX US Collaborative Network, we identified 3744 patients ≤ 17 years old undergoing an index TPE procedure, stratified into four age groups (≤ 1, 2-5, 6-12, and 13-17 years). ICD-10-CM diagnosis codes recorded 30 days prior to the index procedure were mapped to American Society for Apheresis Categories I-III indications; three high-prevalence nonspecific codes were tracked separately. All-cause mortality at 30 days, 90 days, and 1 year was assessed. All-cause mortality decreased with increasing age at every time window: 30-day mortality ranged from 16.8% (≤ 1 year) to 4.3% (13-17 years, p < 0.0001). Infant mortality risk was concentrated disproportionately in the first 90 days postprocedure. Sex distribution shifted from a slight male predominance in infancy and early childhood (55%-56% male) to a female predominance in adolescence (55% female, p < 0.0001). Leading specific indications were autoimmune encephalitis (10%), sepsis with multiorgan failure (9%), renal transplant rejection (6%), acute disseminated encephalomyelitis (5%), Guillain-Barré syndrome (5%), and myasthenia gravis (4%); nonspecific diagnosis codes were each individually more prevalent than any single ASFA-mapped indication. This is the first large-scale, age-stratified, multi-institutional characterization of pediatric TPE. We identified an inverse relationship between age and all-cause mortality, a sex-distribution shift in adolescence, and an indication landscape dominated by nonspecific diagnosis codes. These findings offer age-stratified benchmarks for clinical counseling and hypothesis generation.
SN - 0733-2459
SN - 1098-1101
ER -